Defense Advanced Research Project Agency

If a major global flu pandemic happens, U.S. government and international health care agencies will be hard pressed to manufacture enough vaccine fast enough to keep ahead of the disease. But a research program by the Defense Department’s research and development organization has recently demonstrated the ability to produce ten million of doses of vaccine in just one month.

The goal of the Defense Advanced Research Project Agency’s Blue Angel program is to produce large quantities of high-quality vaccine-grade protein in under three months to respond to a pandemic influenza outbreak. Keep reading →